The eye as a biomarker for Alzheimer's disease

Jeremiah K.H. Lim, Qiao Xin Li, Zheng He, Algis J. Vingrys, Vickie H.Y. Wong, Nicolas Currier, Jamie Mullen, Bang V. Bui, Christine T.O. Nguyen

Research output: Contribution to journalReview article

67 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder resulting in dementia and eventual death. It is the leading cause of dementia and the number of cases are projected to rise in the next few decades. Pathological hallmarks of AD include the presence of hyperphosphorylated tau and amyloid protein deposition. Currently, these pathological biomarkers are detected either through cerebrospinal fluid analysis, brain imaging or post-mortem. Though effective, these methods are not widely available due to issues such as the difficulty in acquiring samples, lack of infrastructure or high cost. Given that the eye possesses clear optics and shares many neural and vascular similarities to the brain, it offers a direct window to cerebral pathology. These unique characteristics lend itself to being a relatively inexpensive biomarker for AD which carries the potential for wide implementation. The development of ocular biomarkers can have far implications in the discovery of treatments which can improve the quality of lives of patients. In this review, we consider the current evidence for ocular biomarkers in AD and explore potential future avenues of research in this area.

Original languageEnglish
Article number536
Number of pages15
JournalFrontiers in Neuroscience
Volume10
DOIs
Publication statusPublished - 17 Nov 2016
Externally publishedYes

Bibliographical note

© 2016. This work is licensed under
http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding
the ProQuest Terms and Conditions, you may use this content in accordance
with the terms of the License.

Keywords

  • Alzheimer's disease
  • Biomarker
  • Eye
  • Neurodegeneration
  • Ocular
  • Retina

Fingerprint Dive into the research topics of 'The eye as a biomarker for Alzheimer's disease'. Together they form a unique fingerprint.

  • Cite this

    Lim, J. K. H., Li, Q. X., He, Z., Vingrys, A. J., Wong, V. H. Y., Currier, N., Mullen, J., Bui, B. V., & Nguyen, C. T. O. (2016). The eye as a biomarker for Alzheimer's disease. Frontiers in Neuroscience, 10, [536]. https://doi.org/10.3389/fnins.2016.00536